Triple Tracer Imaging Approach for the Non-Invasive Assessment of Chemokine Receptor 4 Expression in Gastroenteropancreatic Neuroendocrine Tumors
#1596
Introduction: The theranostic twins [68Ga]Pentixafor and [177Lu]Pentixather for chemokine-directed endoradiotherapy (ERT) were recently developed.
Aim(s): We aimed to evaluate feasibility of non-invasive CXCR4 PET/CT imaging using [68Ga]Pentixafor in comparison to 68Ga-DOTA-D-Phe-Tyr3-octreotide ([68Ga]DOTATOC) and 18F-fluorodeoxyglucose ([18F]FDG).
Materials and methods: 12 patients with histologically proven GEP-NET underwent [68Ga]DOTATOC, [18F]FDG and [68Ga]Pentixafor PET/CT. Scans were analyzed on a patient as well as on a lesion basis.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Werner R
Authors: Werner R, Weich A, Higuchi T, Schmid J, Schirbel A,
Keywords: Neuroendocrine tumor, [68Ga]Pentixafor, CXCR4, PRRT, PET/CT,
To read the full abstract, please log into your ENETS Member account.